Abstract 6873: Discovery and characterization of novel ULK1/2 inhibitors and their ability to degrade ATG13, inhibit autophagy, and treat lung cancer
Year: 2025
Type: conference-abstract
Source: Cancer Research
Institution: Sanford Burnham Prebys Medical Discovery Institute
Language: English
Subfield: Epidemiology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4409634845